BridgeBio Pharma, Inc. (BBIO) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$64.5
Day's range
$66.37

BridgeBio Pharma Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 01/29/2026 16.86 M $1.29 B   0.18% 8.85%
BLACKROCK, INC. 02/12/2026 14.55 M $1.11 B   0.96% 7.64%
VIKING GLOBAL INVESTORS LP 02/17/2026 14.39 M $1.10 B   -9.91% 7.56%
KOHLBERG KRAVIS ROBERTS & CO. L.P. 02/17/2026 13.26 M $1.01 B   0.00% 6.96%
JANUS HENDERSON GROUP PLC 02/17/2026 11.00 M $841.35 M   25.85% 5.77%
FARALLON CAPITAL MANAGEMENT LLC 02/17/2026 9.00 M $688.29 M   9.84% 4.72%
AISLING CAPITAL MANAGEMENT LP 02/10/2026 5.09 M $389.30 M   -16.42% 2.67%
STATE STREET CORP 02/13/2026 4.96 M $379.61 M   -11.48% 2.60%
INVESCO LTD. 02/19/2026 4.83 M $369.55 M   22.98% 2.54%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 4.41 M $344.69 M   12.85% 2.32%
UBS GROUP AG 01/29/2026 3.86 M $295.52 M   0.00% 2.03%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 3.83 M $292.86 M   144.25% 2.01%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/13/2026 3.55 M $271.20 M   -7.80% 1.86%
JANE STREET GROUP, LLC 02/12/2026 3.42 M $261.37 M   2.04% 1.79%
BROOKLANDS FUND MANAGEMENT LTD 02/17/2026 2.75 M $2.81 M   100.00% 1.44%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 2.67 M $204.25 M   -10.34% 1.40%
FMR LLC 02/17/2026 2.39 M $182.84 M   40.55% 1.25%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 2.35 M $179.65 M   130.45% 1.23%
D. E. SHAW & CO., INC. 02/17/2026 2.21 M $169.35 M   -1.72% 1.16%
FRANKLIN RESOURCES INC 02/11/2026 2.16 M $165.60 M   49.92% 1.14%
ALLIANCEBERNSTEIN L.P. 02/17/2026 2.05 M $156.86 M   -11.94% 1.08%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/13/2026 1.98 M $151.01 M   3.16% 1.04%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.96 M $150.26 M   2.04% 1.03%
TWO SIGMA INVESTMENTS, LP 02/17/2026 1.95 M $148.93 M   -16.40% 1.02%
CAPITAL RESEARCH GLOBAL INVESTORS 02/11/2026 1.93 M $147.99 M   0.08% 1.02%
UBS GROUP AG 01/29/2026 1.88 M $143.47 M   -27.48% 0.98%
SC US (TTGP), LTD. 02/13/2026 1.86 M $142.30 M   0.00% 0.98%
GOLDMAN SACHS GROUP INC 03/25/2026 1.78 M $136.37 M   -19.30% 0.94%
MACQUARIE MANAGEMENT HOLDINGS, INC. 02/17/2026 1.73 M $131.97 M   100.00% 0.91%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/17/2026 1.68 M $128.58 M   1.14% 0.88%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 1.59 M $121.82 M   149.14% 0.84%
NORGES BANK 02/10/2026 1.53 M $116.80 M   100.00% 0.80%
LAURION CAPITAL MANAGEMENT LP 02/17/2026 1.40 M $107.25 M   -20.04% 0.74%
TWO SIGMA ADVISERS, LP 02/17/2026 1.40 M $107.17 M   -15.74% 0.74%
MORGAN STANLEY 02/13/2026 1.40 M $107.07 M   32.70% 0.73%
NORTHERN TRUST CORP 02/17/2026 1.35 M $103.01 M   -3.97% 0.71%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 1.31 M $100.53 M   3.70% 0.69%
POLAR CAPITAL HOLDINGS PLC 02/17/2026 1.30 M $99.39 M   32.44% 0.68%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 1.27 M $96.96 M   12.08% 0.67%
ENSIGN PEAK ADVISORS, INC 02/12/2026 1.26 M $96.64 M   -6.52% 0.66%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/17/2026 1.26 M $96.01 M   0.94% 0.66%
CORMORANT ASSET MANAGEMENT, LP 02/17/2026 1.20 M $91.79 M   -14.29% 0.63%
AMERICAN CENTURY COMPANIES INC 02/13/2026 1.11 M $84.66 M   2.81% 0.58%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.08 M $82.46 M   -21.93% 0.57%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 01/15/2026 994.22 K $77.78 M   14,211.50% 0.52%
JPMORGAN CHASE & CO 02/11/2026 858.97 K $65.70 M   192.05% 0.45%
AMERIPRISE FINANCIAL INC 02/17/2026 841.54 K $64.37 M   5.10% 0.44%
FRONTIER CAPITAL MANAGEMENT CO LLC 02/17/2026 826.13 K $63.19 M   25.24% 0.43%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 02/17/2026 813.79 K $62.25 M   0.88% 0.43%
DEEP TRACK CAPITAL, LP 02/13/2026 810.14 K $61.97 M   -32.49% 0.43%

BridgeBio Pharma Inc institutional Ownership - FAQ's

During the previous two years, 576 institutional investors and hedge funds held shares of BridgeBio Pharma Inc. The most heavily invested institutionals were:

Aisling Capital Management LP: 5.09 M

Invesco Ltd.: 4.59 M

UBS Group AG: 2.03 M

JANE STREET GROUP, LLC: 1.76 M

Pictet Asset Management Holding SA: 1.38 M

PRINCIPAL FINANCIAL GROUP INC: 1.33 M

100.29% of BridgeBio Pharma Inc stock is owned by institutional investors.

Institutional investors have bought a total of 216.94 M shares in the last 24 months. This purchase volume represents approximately $14.24 B in transactions.